Rare peritoneal tumour presenting as uterine fibroid

Tumour arising from the uterus in the reproductive age group commonly belongs to benign category, the myoma uterus. Here we present a case report of a 22yr old primiparous mother with uterine metastasis from a rare peritoneal malignancy desmoplastic small round cell tumour who presented as uterine myoma. Desmoplastic small round cell tumour is a rare aggressive neoplasm arising from mesothelial cell, with poor prognosis. This woman presented with excessive bleeding per vaginum in the postpartum period,3months after caesarean section.24weeks  enlarged uterine mass found for which uterine artery embolisation was done in vain, later she was planned to undergo myomectomy. But due to widespread uterine mass, hysterectomy was done which led to the diagnosis of this rare neoplasm

Retrospective study of 53 cases of caesarean myomectomy regarding its safety and feasibility

Background: In recent era, many studies have come up stating the safety and feasibility of caesarean myomectomy. With the advances in surgical techniques, the risk is very minimum. Our primary objective is to evaluate the safety of caesarean myomectomy and to analyse the blood loss according to the size, site of fibroids and with various methods used to prevent blood loss and postoperative morbidity.Methods: Retrospective studies of 53 women were included in our study who underwent caesarean myomectomy in the period of June 2006 to June 2015. Site, Size and number of myomas removed were noted down. Hemoglobin difference between pre and postoperative levels also noted down.Results: There is no significant blood loss difference according to the type, number and methods used to prevent blood loss. But as the size increases, there is significant blood loss difference- P value 0.006.Conclusions: Caesaren myomectomy can be safely undertaken by experienced surgeons. Single or multiple, smaller subserosal and intramural myomas can be safely removed .Though larger fibroids have increased blood loss intraoperative, with the prophylactic measures, we can safely remove them too. Submucosal, cornual myomas have to be dealt with caution

Clinical study of risk factors and ultrasonographic correlation of endometrial hyperplasia according to the WHO classification 2014

Background: Type 1 endometrial carcinoma is usually preceded by atypical hyperplasia. Nonatypical hyperplasia should be managed conservatively and atypical hyperplasia have to be managed aggressively. So, the diagnosis is crucial for its management.Methods: The study population included women diagnosed with endometrial hyperplasia by histopathology as per WHO classification 2014 from the year January 2015 to February 2020.Women with endometrial polyp diagnosed by transvaginal ultrasonography and histopathology were excluded. Primary objective was to compare the endometrial thickness between the two types of hyperplasia. Secondary objective was to analyses the risk factors of the two types.Results: In multivariate analysis of logistic regression, diabetic women have 1.57 times risk of developing atypia and obese women have 3.12 times risk of developing atypia. Polycystic ovarian disease is having borderline significance for causing atypia. There was significant difference in endometrial thickness between atypical and nonatypical hyperplasia (P=0.040). In premenopausal women, (P=0.069) the thickness difference in atypia is of only borderline significance. Heteroechoic pattern or cystic spaces in the endometrium also didn’t predict atypia.Conclusions: Mean endometrial thickness is significantly different in atypical hyperplasia. Heteroechoic pattern of endometrium do not predict atypia. We need color doppler sonography to gain knowledge about atypia. Obesity and diabetes mellitus are significant risk factors of atypia

Retrospective study of 53 cases of caesarean myomectomy regarding its safety and feasibility

Background: In recent era, many studies have come up stating the safety and feasibility of caesarean myomectomy. With the advances in surgical techniques, the risk is very minimum. Our primary objective is to evaluate the safety of caesarean myomectomy and to analyse the blood loss according to the size, site of fibroids and with various methods used to prevent blood loss and postoperative morbidity.Methods: Retrospective studies of 53 women were included in our study who underwent caesarean myomectomy in the period of June 2006 to June 2015. Site, Size and number of myomas removed were noted down. Hemoglobin difference between pre and postoperative levels also noted down.Results: There is no significant blood loss difference according to the type, number and methods used to prevent blood loss. But as the size increases, there is significant blood loss difference- P value 0.006.Conclusions: Caesaren myomectomy can be safely undertaken by experienced surgeons. Single or multiple, smaller subserosal and intramural myomas can be safely removed .Though larger fibroids have increased blood loss intraoperative, with the prophylactic measures, we can safely remove them too. Submucosal, cornual myomas have to be dealt with caution